These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9592062)

  • 1. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum.
    Schneider JS; Wade T; Lidsky TI
    Neuroreport; 1998 Jan; 9(1):133-6. PubMed ID: 9592062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
    Rothblat DS; Schneider JS
    Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain.
    Schmitt A; Zink M; Petroianu G; May B; Braus DF; Henn FA
    Neurosci Lett; 2003 Aug; 347(2):81-4. PubMed ID: 12873733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
    Wirtshafter D
    Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine.
    Melone M; Vitellaro-Zuccarello L; Vallejo-Illarramendi A; Pérez-Samartin A; Matute C; Cozzi A; Pellegrini-Giampietro DE; Rothstein JD; Conti F
    Mol Psychiatry; 2001 Jul; 6(4):380-6. PubMed ID: 11443521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum.
    Hiroi N; Graybiel AM
    J Comp Neurol; 1996 Oct; 374(1):70-83. PubMed ID: 8891947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum.
    Healy DJ; Meador-Woodruff JH
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):331-8. PubMed ID: 9221932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses.
    Meshul CK; Bunker GL; Mason JN; Allen C; Janowsky A
    J Neurochem; 1996 Nov; 67(5):1965-73. PubMed ID: 8863502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of GABA and glutamate transporter messenger RNAs in the severe-seizure genetically epilepsy-prone rat.
    Akbar MT; Rattray M; Williams RJ; Chong NW; Meldrum BS
    Neuroscience; 1998 Aug; 85(4):1235-51. PubMed ID: 9681960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Neuropharmacology; 2008 Mar; 54(4):745-54. PubMed ID: 18222493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat.
    Angulo JA; Cadet JL; McEwen BS
    Neurosci Lett; 1990 May; 113(2):217-21. PubMed ID: 1974041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments.
    Delfs JM; Anegawa NJ; Chesselet MF
    Neuroscience; 1995 May; 66(1):67-80. PubMed ID: 7637876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain.
    Collins CM; Wood MD; Elliott JM
    J Psychopharmacol; 2014 Oct; 28(10):947-54. PubMed ID: 24989643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.
    Merchant KM; Dobie DJ; Filloux FM; Totzke M; Aravagiri M; Dorsa DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):460-71. PubMed ID: 7965747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glutamate transporter (GLT-1) immunoreactivity in the rat striatum after repeated intermittent administration of methamphetamine.
    Nishino N; Shirai Y; Kajimoto Y; Kitamura N; Yamamoto H; Yang CQ; Shirakawa O
    Ann N Y Acad Sci; 1996 Oct; 801():310-4. PubMed ID: 8959043
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum.
    Gupta SK; Mishra RK
    J Mol Neurosci; 1992; 3(4):197-201. PubMed ID: 1390000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: implications for the pathogenesis of neuroleptic-induced movement disorders.
    Auchus AP; Pickel VM
    Exp Neurol; 1992 Jul; 117(1):17-27. PubMed ID: 1618284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of haloperidol and clozapine on Fos expression in the primate striatum.
    Wirtshafter D; Asin KE
    Neuroreport; 2003 Dec; 14(18):2429-32. PubMed ID: 14663205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics.
    Bardgett ME; Wrona CT; Newcomer JW; Csernansky JG
    Eur J Pharmacol; 1993 Jan; 230(3):245-50. PubMed ID: 8095021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.